LE210101 | Meningococcal


© Copyright 2021 Linear Clinical Research Ltd.

4 appointments

3 Phone Calls


Vaccine Study

Study Schedule

To qualify, you must:

  • Be male or female aged between 18 and 40 years old
  • Not have received the meningococcal vaccine MEN ACWY in the last 4 years
  • Not have received received the meningococcal vaccine MEN C after turning 2 years old
  • Have NEVER received the meningococcal vaccine MEN B

How Will Your Contribution Help?

You will help us test an investigational vaccine to help us assess its safety and see if it helps protect against the 5 most common types of meningococcal germs that can cause disease in Australia. This study may also help us learn more about meningococcal disease!

3 Benefits For our Volunteers

Give back to your community.

Contribute to important medical research.

Get paid for your contribution. Remuneration is based on completion of all study requirements.


4 Steps to Help Medical Research

Who is Linear, why should I do a trial with you?

As a world class leader, Linear Clinical Research (Linear) is a purpose built state-of-the-art, clinical trials facility operating out of QEII Medical Centre in Perth, Western Australia. Clinical trials are a crucial part of the process of developing, licensing and bringing new drugs and therapies to patients. Trials test new treatments for safety and efficacy, enabling medical practitioners and patients to use them confidently. Every medication currently available has gone through a clinical trial process. 

Will I be given any Meningococcus germs?

No. As a volunteer, you will not be given any infectious meningococcus germs. Trial participation involves testing a new investigational vaccine in healthy participants to assess the safety and tolerability. Therefore, there is no need to expose you to meningococcal germs which can cause disease at any point throughout the trial.

If I am healthy how can I participate in the study?

Healthy volunteers play an important role in the development of a new medication or treatment. Before the treatment can be administered to patients with a particular condition or disease, it undergoes a comprehensive testing process which includes “early phase” testing to assess the general safety, and any potential side effects, in people who are healthy so that the precise effects of the treatment can be determined.

How safe are trials?

Every trial at Linear requires approval by an independent ethics committee – registered with the Australian Government’s National Health and Medical Research Council (NHMRC). Linear follows regulations and guidelines in accordance with international certification under Good Clinical Practice (GCP) and in accordance with TGA (Australia), FDA (USA), EMA (EU) and Medicines Australia guidelines.

Read our Meningococcal Vaccine Study FAQs

Spots are limited. Find out if you qualify today!